A Peek at ResMed's Future Earnings

ResMed (NYSE:RMD) is set to give its latest quarterly earnings report on Thursday, 2024-10-24. Here's what investors need to know before the announcement.

Analysts estimate that ResMed will report an earnings per share (EPS) of $2.04.

ResMed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Overview of Past Earnings

Last quarter the company beat EPS by $0.02, which was followed by a 4.23% increase in the share price the next day.

Here's a look at ResMed's past performance and the resulting price change:

Quarter

Q4 2024

Q3 2024

Q2 2024

Q1 2024

EPS Estimate

2.06

1.91

1.79

1.62

EPS Actual

2.08

2.13

1.88

1.64

Price Change %

4.0%

19.0%

8.0%

-3.0%

Market Performance of ResMed's Stock

Shares of ResMed were trading at $239.98 as of October 22. Over the last 52-week period, shares are up 70.56%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

Analysts' Perspectives on ResMed

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on ResMed.

Analysts have given ResMed a total of 8 ratings, with the consensus rating being Neutral. The average one-year price target is $235.38, indicating a ...